Digital Health Event Highlights Innovation, Wireless Clinical Trials
Summary
The headliners event, organized by Qualcomm Life and CommNexus, the San Diego nonprofit industry group, includes Rick Valencia, who oversees Qualcomm Life; Resmed (NYSE: RMD) COO Robert Douglas; Kevin Patrick, director of the UC San Diego Center for Wireless and Population Health Systems; and Greg Lucier, the former chairman and CEO of Life Technologies, now part of Thermo Fisher Scientific (NYSE: TMO).“Eleven years is the longest I’ve stayed with one company and it was a great time to be at Qualcomm and to introduce the healthcare industry to wireless technologies,” Jones writes.“We built out a phenomenal ecosystem of university programs, master degrees for engineers and physicians, investment funds, innovation programs, the Qualcomm Tricorder XPrize, FDA relationships, standards bodies, regulatory and policy groups, and much more.” At tomorrow’s headliner event, “my topic will be that mobility in healthcare is here to stay, connectivity made it happen and now the challenge is to get a network effect,” he added.“Pharma, medical device [makers] and health payers all accept clinical validation as a necessary hurdle to adoption and reimbursement.Increasingly, consumer electronic companies, telcos, and even international food and supplement companies are planning and conducting clinical trials of their digital health products.” At Scripps new digital medicine center, Steinhubl is overseeing the design and execution of the mHealth technology clinical trials.